Literature DB >> 25610018

Epidemiological factors affecting hepatitis a seroprevalence in childhood in a developing country.

Sevin Altınkaynak1, Mukadder Ayşe Selimoğlu2, Vildan Ertekin3, Buket Kılıçaslan4.   

Abstract

OBJECTIVE: The aim of this study was to determine the prevalence rate of hepatitis A virus (HAV) and the socio-epidemiological factors affecting HAV among children aged 0-18 years in Eastern Turkey.
MATERIALS AND METHODS: The study sample consisted of 226 children aged 0-18 years who were registered at the Pediatrics Department of Atatürk University Medical Faculty for any reason except jaundice between January and May 2002. The presence of anti-HAV immunoglobulin G (IgG) in the children was determined by ELISA.
RESULTS: The percentage of HAV IgG seropositivity among the 226 children was 59.7%. We detected an increase of HAV prevalence with age. The prevalence of HAV did not differ significantly in relation to gender. HAV prevalence was higher in children of rural areas than in children of urban and suburban areas (P<0.001). Only two of the 226 children had received the HAV vaccine. The percentage of HAV IgG seropositivity of unvaccinated children was 59.3%. HAV seroprevalence was higher in subjects who had a history of jaundice (84.6%) than in those who did not (58.2%). An increase in HAV prevalence was observed with a decrease in socio-economic status (P<0.001).
CONCLUSION: HAV prevalence was markedly high, but HAV vaccination of children was very low in Erzurum. The socio-demographic factors of age, settlement area, and socio-economic status of family were significantly associated with HAV prevalence.

Entities:  

Keywords:  Children; Hepatitis A; Seroepidemiology

Year:  2008        PMID: 25610018      PMCID: PMC4261326     

Source DB:  PubMed          Journal:  Eurasian J Med        ISSN: 1308-8734


  15 in total

1.  Prevalence and persistence of hepatitis A antibody during the first year of life, in Turkish infants.

Authors:  M Alikasifoglu; A Arvas; Y Tastan; E Tasdelen; F Cullu; O Ilter; S Badur; D Yüksel
Journal:  Indian Pediatr       Date:  1999-11       Impact factor: 1.411

2.  Hepatitis A seroprevalence in a random sample of the Turkish population by simultaneous EPI cluster and comparison with surveys in Turkey.

Authors:  Güler Kanra; Sabahat Tezcan; Selim Badur
Journal:  Turk J Pediatr       Date:  2002 Jul-Sep       Impact factor: 0.552

3.  Current seroepidemiology of hepatitis A in Hong Kong.

Authors:  K P Chin; A S Lok; L S Wong; C L Lai; P C Wu
Journal:  J Med Virol       Date:  1991-07       Impact factor: 2.327

Review 4.  Hepatitis A.

Authors:  R S Koff
Journal:  Lancet       Date:  1998-05-30       Impact factor: 79.321

Review 5.  Changing epidemiology and clinical aspects of hepatitis A.

Authors:  A Forbes; R Williams
Journal:  Br Med Bull       Date:  1990-04       Impact factor: 4.291

6.  Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

Authors: 
Journal:  MMWR Recomm Rep       Date:  1996-12-27

7.  Exposure of Indian children to hepatitis A virus & vaccination age.

Authors:  M S Chadha; S D Chitambar; N J Shaikh; V A Arankalle
Journal:  Indian J Med Res       Date:  1999-01       Impact factor: 2.375

8.  Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992.

Authors:  V A Arankalle; S A Tsarev; M S Chadha; D W Alling; S U Emerson; K Banerjee; R H Purcell
Journal:  J Infect Dis       Date:  1995-02       Impact factor: 5.226

9.  Distribution of antibody to hepatitis a antigen in urban adult populations.

Authors:  W Szmuness; J L Dienstag; R H Purcell; E J Harley; C E Stevens; D C Wong
Journal:  N Engl J Med       Date:  1976-09-30       Impact factor: 91.245

Review 10.  Cost-effectiveness of hepatitis A vaccination in children, adolescents, and adults.

Authors:  Philip Rosenthal
Journal:  Hepatology       Date:  2003-01       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.